Stay up to date with information about our company and products

9 March 2022

Let’s meet in Basel at the LSX RNA Leaders World Congress 2022!

Join Tomasz Piec, President of Supervisory Board, and Dominik Lipka, Director of Research and Development, Board Member and let’s discuss the potential opportunities of cooperation.
SyVento offers the development of encapsulated drugs for all kinds of pharmaceutically active ingredients based on various lipid-based formulations including Lipid Nanoparticles (LNP) for RNA.
The Congress brings together the leading companies developing RNA-based therapeutics and is a global platform for advancing scientific and commercial collaborations, as well as sharing the recent advances and challenges of the field.

We use cookies and similar technologies, including for the purposes of: providing services, advertising, statistics. Using the site without changing your browser settings means that they will be placed on your end device. Remember that you can always change these settings.